Skip to main navigation Skip to search Skip to main content

Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung

  • R. T. Eagan
  • , S. Frytak
  • , E. T. Creagan
  • , J. N. Ingle
  • , L. K. Kvols
  • , D. T. Coles

Research output: Contribution to journalArticlepeer-review

Abstract

The evaluation of cyclophosphamide, Adriamycin, and cis-platinum given by 6-hour infusion with mannitol (CAP-II) is the subject of this report. Forty-two patients, 22 with adenocarcinoma (ACA) and 20 with large cell carcinoma (LCC) of the lung, were entered in the study.

Original languageEnglish (US)
Pages (from-to)1589-1591
Number of pages3
JournalCancer Treatment Reports
Volume63
Issue number9-10
StatePublished - 1979

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung'. Together they form a unique fingerprint.

Cite this